Impaired innate immune alveolar macrophage response and the predilection for copd exacerbations

Thorax

Volumn 69, Issue 9, 2014, Pages 811-818

  Berenson, Charles S ^a   Kruzel, Ragina L ^a   Eberhardt, Ellana ^a   Dolnick, Ree ^b   Minderman, Hans ^b   Wallace, Paul K ^b   Sethi, Sanjay ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRIPALMITOYL CYSTEINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIBODY LABELING; ARTICLE; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLORIMETRY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STREPTOCOCCUS PNEUMONIAE;

COPD EXACERBATIONS; CYTOKINE BIOLOGY; INNATE IMMUNITY; MACROPHAGE BIOLOGY;

CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE PROGRESSION; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-8; LIGANDS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; NF-KAPPA B; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84905966661     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203669     Document Type: Article

References (34)

1. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012;379:1341-51.
2. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355-65.
3. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60:925-31. (Pubitemid 41598207)
4. Berenson CS, Wrona CT, Grove LJ, et al. Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease. Am J Resp Crit Care Med 2006;173:991-8.
5. Berenson CS, Garlipp MA, Grove LJ, et al. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis 2006;194:1375-84. (Pubitemid 44706505)
6. Murphy TF, Brauer AL, Schiffmacher AT, et al. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:266-72. (Pubitemid 38971411)
7. Sethi S, Wrona C, Grant BJ, et al. Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;169:448-53. (Pubitemid 38187115)
8. Murphy TF, Parameswaran GI. Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis 2009;49:124-31.
9. Murphy TF, Brauer AL, Aebi C, et al. Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease. Infect Immun 2005;73:8161-6. (Pubitemid 41740304)
10. Calbo E, Valdés E, Ochoa de Echagüen A, et al. Bacteraemic pneumococcal pneumonia in COPD patients: better outcomes than expected. Eur J Clin Microbiol Infect Dis 2009;28:971-6.
11. Malley R, Lipsitch M, Bogaert D, et al. Serum antipneumococcal antibodies and pneumococcal colonization in adults with chronic obstructive pulmonary disease. J Infect Dis 2007;196:928-35. (Pubitemid 47378944)
12. Abe Y, Murphy TF, Sethi S, et al. Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;165:967-71. (Pubitemid 34774666)
13. Patel IS, Seemungal TA, Wilks M, et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57:759-64. (Pubitemid 34984972)
14. Bhowmik A, Seemungal TA, Sapsford RJ, et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000;55:114-20. (Pubitemid 30245950)
15. Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-71. (Pubitemid 34879333)
16. Earley M, Vogt R, Shapiro H, et al. Report from a workshop on multianalyte microsphere assays. Cytometry 2002;50:239-42.
17. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
18. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176:532-55. (Pubitemid 47403272)
19. Murphy TF. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis 2006;19:225-30. (Pubitemid 43740359)
20. Hurst JR, Perera WR, Wilkinson TM, et al. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:71-8. (Pubitemid 43069790)
21. Doz E, Noulin N, Boichot E, et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol 2008;180:1169-78.
22. Wieland CW, Florquin S, Maris NA, et al. The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable Haemophilus influenzae from the mouse lung. J Immunol 2005;175:6042-9. (Pubitemid 41508090)
23. Moghaddam SJ, Clement CG, De la Garza MM, et al. Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype. Am J Respir Cell Mol Biol 2008;38:629-38. (Pubitemid 351841563)
24. Carmody RJ, Chen YH. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell Mol Immunol 2007;4:31-41.
25. von Scheele I, Larsson K, Dahlen B, et al. Toll-like receptor expression in smokers with and without COPD. Resp Med 2010;105:1222-30.
26. Sarir H, Mortaz E, Karimi K, et al. Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages. J Inflamm 2009;6:1-9.
27. Droemann D, Goldmann T, Tiedje T, et al. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Resp Res 2005;6:1-8.
28. Wedzicha JA. Exacerbations: etiology and pathophysiologic mechanisms. Chest 2002;121:136S-41S. (Pubitemid 34497331)
29. Parameswaran GI, Wrona CT, Murphy TF, et al. Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease. BMC Infect Dis 2009;9:178.
30. Tanino M, Betsuyaku T, Takeyabu K, et al. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 2002;57:405-11. (Pubitemid 34494150)
31. Sethi S, Maloney J, Grove L, et al. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:991-8.
32. Schulz C, Krätzel K, Wolf K, et al. Activation of bronchial epithelial cells in smokers without airway obstruction and patients with COPD. Chest 2004;125:1706-13. (Pubitemid 38648401)
33. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.
34. Harvey CJ, Thimmulappa RK, Sethi S, et al. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Transl Med 2011;3:78ra32.